Target intelligence / Profile preview

Human metapneumovirus fusion protein (hMPV F)

Target
hMPV F
Molecular classification
Viral glycoprotein, Class I viral fusion protein
01

Overview

The Human metapneumovirus (hMPV) fusion (F) protein is a class I viral fusion glycoprotein that is essential for the virus to enter host cells by mediating the fusion of the viral envelope with the host cell membrane. It exists in two primary conformations: a metastable prefusion state and a stable postfusion state. The prefusion-stabilized form is a critical target for vaccine development and therapeutic antibodies because it displays the most potent neutralizing epitopes, which are often lost during the transition to the postfusion state. By targeting the prefusion F protein, drugs and vaccines aim to elicit or provide antibodies that block the conformational change or sterically hinder membrane fusion, thereby preventing infection. This target is particularly relevant for protecting vulnerable populations, such as infants, the elderly, and the immunocompromised, from severe respiratory tract infections like bronchiolitis and pneumonia.

Other names
hMPV fusion glycoproteinPrefusion-stabilized hMPV F proteinhMPV F-DS-Cav1hMPV F-triHuman metapneumovirus F protein
02

Mechanism of action

Neutralization of viral infection by binding to the prefusion conformation of the F protein, thereby preventing the structural transition to the postfusion state required for membrane fusion and viral entry into host cells.

03

Biological functions

Viral entryMembrane fusionViral attachment
04

Disease associations

Human metapneumovirus infectionBronchiolitisPneumoniaLower respiratory tract infection
05

Safety considerations

Vaccine-associated enhanced respiratory disease (VAERD)Antibody-dependent enhancement (ADE)Local and systemic reactogenicity
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Serum neutralizing antibody titershMPV viral load

Beyond the preview

Go deeper on Human metapneumovirus fusion protein (hMPV F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human metapneumovirus fusion protein (hMPV F).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call